The effects of chronic cadmium toxicity on the hemostatic system

Pathophysiology of Haemostasis and Thrombosis

Volumn 35, Issue 6, 2006, Pages 411-416

  Koçak, Mehtap ^a,b   Akçil, Ethem ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Blood platelets; Cadmium; Chronic toxicity; Partial thromboplastin time; Prothrombin time

Indexed keywords

ANTITHROMBIN; CADMIUM; CADMIUM CHLORIDE; PROTEIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLOOD LEVEL; CADMIUM POISONING; CONTROLLED STUDY; HEMOSTASIS; KIDNEY PROXIMAL TUBULE; LONG TERM EXPOSURE; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RAT; THROMBOCYTE COUNT;

ANEMIA; ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CADMIUM; CADMIUM CHLORIDE; ENVIRONMENTAL POLLUTANTS; KIDNEY DISEASES; MALE; OSTEOMALACIA; PLATELET COUNT; PROTEIN C; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 34250174160     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102047     Document Type: Article

References (64)

1. Tsalev DL: Cadmium; in Tsalev DL (ed): Atomic Absorption Spectrometry in Occupational and Environmental Health Practice. Florida, CRC Press, 1993, vol 1, chap 2, pp 105-112.
2. Brzoska MM., Moniuszko-Jakoniuk J: The influence of calcium content in diet on cumulation and toxicity of cadmium in the organism. Arch Toxicol 1998;72:63-73.
3. El-Agha O, Gokmen IG: Smoking habits and cadmium intake in Turkey. Biol Trace Elem Res 2002;88:31-43.
4. Garty M, Wong KL, Klaassen CD: Redistribution of cadmium to blood of rats. Toxicol Appl Pharmacol 1981;59:548-554.
5. Templeton DM: Cadmium uptake by cells of renal origin. J Biol Chem 1990;265:21764-21770.
6. Zalups RK, Ahmad S: Molecular handling of cadmium in transporting epithelia. Toxicol Appl Pharmacol 2003;186:163-188.
7. Klaassen CD, Liu J: Role of metallothionein in cadmium-induced hepatotoxicity and nephrotoxicity. Drug Metab Rev 1997;29:79-102.
8. +-ATPase through proteasomal and endo-lysosomal proteolytic pathways. FASEB J 1999;13:1751-1761.
9. Perry HM Jr, Erlanger MW: Metal-induced hypertension following chronic feeding of low doses of cadmium and mercury. J Lab Clin Med 1974;83:541-547.
10. Fowler BA, Jones HS, Brown HW, Haseman JK: The morphologic effects of chronic cadmium administration on the renal vascularite of rats given low and normal calcium diets. Toxicol Appl Pharmacol 1975;34:237-252.
11. Perry HM Jr, Erlanger MW, Perry EF: Hypertension following chronic, very low-dose cadmium feeding. Proc Soc Exp Biol Med 1977;156:173-176.
12. Niwa A, Suzuki A: Effects of cadmium on the tension of isolated rat aorta (a possible mechanism for cadmium induced hypertension). J Toxicol Sci 1982;7:51-60.
13. Mikhaleva LM, Zhavoronkov AA, Cherniaev AL, Koshelev VB: Morphofunctional characteristics of cadmium-induced arterial hypertension. Biull Eksp Biol Med 1991;111:420-423.
14. Öner G, Şentürk ÜK, Izgüt-Uysal NV: The role of atrial natriuretic peptide in cadmium-induced hypertension. J Turk Elements Exp Med 1995;8:147-153.
15. Öner G, Şentürk ÜK, Izgüt-Uysal NV: Role of cadmium-induced lipid peroxidation in the kidney response to atrial natriuretic hormone. Nephron 1996;72:257-262.
16. Waner T, Gur E: Effects of cadmium on erythrocytic parameters. Vet Clin Pathol 1993;22:25-27.
17. Mackova NO, Lenikova S, Fedorocko P, Brezani P, Fedorockova A: Effects of cadmium on haemopoiesis in irradiated and non-irradiated mice. 2. Relationship to the number of circulating blood cells and haemopoiesis. Physiol Res 1996;45:101-106.
18. 2) on cell proliferation and production of EDRF (endothelium-derived relaxing factor) by cultured human umbilical cord arterial endothelial cells. Arch Toxicol 1994;68:555-559.
19. Yamamoto C, Kaji T, Sakamoto M, Kozuka H: Effects of cadmium on the release of tissue plasminogen activator and plasminogen activator inhibitor type 1 from cultured human vascular smooth muscle cells and fibroblasts. Toxicology 1996;106:179-185.
20. Kaji T, Suzuki M, Yamamoto C, Imaki Y, Miyajima S, Fujiwara Y, Sakamoto M, Kozuka H: Sensitive response of cultured vascular smooth-muscle cells to cadmium cytotoxicity: comparison with cultured vascular endothelial cells and kidney epithelial LLC-PK1 cells. Toxicol Lett 1996;89:131-137.
21. Fujiwara Y, Watanabe S, Kaji T: Promotion of cultured vascular smooth muscle cell proliferation by low levels of cadmium. Toxicol Lett 1998;94:175-180.
22. Grabowska-Maslanka A, Janik A, Chlap Z, Szuperska-Ocetkiewicz A, Slawinski M, Grylewski RJ, Korbut R: Influence of cadmium intoxication on thromboresistance of vascular endothelium in rabbits. J Physiol Pharmacol 1998;49:1:61-70.
23. Kumar SV, Bose R, Bhattacharya S: Low doses of heavy metals disrupt normal structure and function of rat platelets. J Environ Pathol Toxicol Oncol 2001;20:65-75.
24. Sato M, Nagai Y: Sex-related differences in NADPH-dependent lipid peroxidation induced by cadmium. Arch Toxicol 1986;59:156-159.
25. Nishiyima S, Onosaka S, Taguchi T, Konishi Y, Tanaka K, Kinebuchi H: Stimulation of cadmium uptake by estradiol in the kidney of male rats treated with cadmium. Biochem Pharmacol 1998;37:3091-3096.
26. Kiukuchi Y, Nomiyama T, Kumagai N, Dekio F, Uemura T, Takebayashi T, Nishiwaki Y, Matsumoto Y, Sano Y, Hosoda K, Watanabe S, Sakurai H, Omae K: Uptake of cadmium in meals from the digestive tract of young non-smoking Japanese female volunteers. J Occup Health 2003;45:43-52.
27. Milestone Acid Digestion Cookbook (Update 01/01/1996): Blood. Sorisole, Milestone Microwave Laboratory Systems, 1996, p 23.
28. Perry EF, Koirtyohann SR, Perry HM: Determination of cadmium in blood and urine by graphite furnace atomic absorption spectrophotometry. Clin Chem 1975;21:626-629.
29. Tsalev DL: Cadmium; in Tsalev DL (ed): Atomic Absorption Spectrometry in Occupational and Environmental Health Practice. Florida, CRC Press, 1993, vol 2, chap 8, pp 39-49.
30. Makris TK, Stavroulakis GA, Hatzizacharias AN, Krepsi PG, Margos P, Tsoukala C, Mandalaki T, Votteas VV: Parenteral history of hypertension is associated with coagulation-fibrinolytic balance disorders. Thromb Res 2003;111:45-49.
31. Villaggi F, Ratti G: Dade Behring Manual Book. Marburg, Dade Behring, 1997.
32. Deitcher SR, Rodgers GM: Thrombosis and antithrombotic therapy; in Greer JP, Rodgers GM, Foerster J, Paraskevas F, Lukens JN, Glader B (eds): Wintrobe's Clinical Hematology, ed 11. Philadelphia, Lippincott Williams & Wilkins, 2003, vol 2, chap 61, pp 1714-1724.
33. Kayama F, Yoshida T, Elwell MR, Luster MI: Role of tumor necrosis factor-α in cadmium-induced hepatotoxicity. Toxicol Appl Pharmacol 1995;131:224-234.
34. Habeebu SSM, Liu J, Klaassen CD: Cadmium-induced apoptosis in mouse liver. Toxicol Appl Pharmacol 1998;149:203-209.
35. Kondoh M, Ogasawara S, Araragi S, Higashimoto M, Sato M: Cytochrome c release from mitochondria induced by cadmium. J Health Sci 2001;47:78-82.
36. Prasada Rao PV: Effects of intraperitoneal cadmium administration on mitochondrial enzymes in rat tissues. Toxicology 1983;27:81-87.
37. Prasada Rao PV, Gardner DE: Effects of cadmium inhalation on mitochondrial enzymes in rat tissues. J Toxicol Environ Health 1986;17:191-199.
38. Muller L, Stacey NH: Subclinical response to cadmium in liver cells. Biol Trace Elem Res 1989;21:317-323.
39. Kataranovski M, Kataranovski D, Savic D, Jovcic G, Bogdanovic Z, Jovanovic T: Granulocyte and plasma cytokine activity in acute cadmium intoxication in rats. Physiol Res 1998;47:453-461.
40. Chen L, Zhou J, Gao W, Jiang YZ: Action of NO and TNF-α release of rats with cadmium loading in malfunction of multiple system organ. Sheng Li Xue Bao 2003;55:535-540.
41. Esmon CT: Does inflammation contribute to thrombotic events? Haemostasis 2000;30:34-40.
42. Nawroth PP, Stern DM: Tumor necrosis factor/cachectin-induced modulation of endothelial cell haemostatic properties. Onkologie 1987;10:254-258.
43. Bauer KA, Ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD: Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989;74:165-172.
44. Okafuji T, Maekawa K, Nawa K, Marumoto Y: The cDNA cloning and mRNA expression of rat protein C. Biochim Biophys Acta 1992;1131:329-332.
45. Jamison CS, McDowell SA, Marlar RA, Degen SJ: Developmental expression of protein C and protein S in the rat. Thromb Res 1995;78:407-419.
46. Yamamoto K, Loskutoff DJ: Extrahepatic expression and regulation of protein C in the mouse. Am J Pathol 1998;153:547-555.
47. Stief TW, Radtke K, Heimburger N: Inhibition of urokinase by protein C-inhibitor (PCI): evidence for identity of PCI and plasminogen activator inhibitor 3 (PAI 3). Biol Chem 1987;368:1427-1433.
48. Radtke KP, Fernández JA, Greengard JS, Tang WW, Wilson CB, Loskutoff DJ, Scharrer I, Griffin JH: Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest 1994;94:2117-2124.
49. Wang XP, Chan HM, Goyer RA, Cherian MG: Nephrotoxicity of repeated injections of cadmium-metallothionein in rats. Toxicol Appl Pharmacol 1993;119:11-16.
50. Hamada T, Tanimoto A, Iwai S, Fujiwara H, Sasaguri Y: Cytopathological changes induced by cadmium-exposure in canine proximal tubular cells: a cytochemical and ultrastructural study. Nephron 1994;68:104-111.
51. Thevenod F: Nephrotoxicity and the proximal tubule: insights from cadmium. Nephron Physiol 2003;93:87-93.
52. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM: Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-3561.
53. Szuster-Ciesielska A, Stachura A, Slotwinska M, Kaminska T, Sniezko R, Paduch R, Abramczyk D, Filar J, Kandefer-Szerszen M: The inhibitory effect of zinc on cadmium-induced cell apoptosis and reactive oxygen species (ROS) production in cell cultures. Toxicology 2000;145:159-171.
54. Kostic MM, Ognjanovic B, Dimitrijevic S, Zikic RV, Stajn A, Rosic GL, Zivkovic RV: Cadmium-induced changes of antioxidant and metabolic status in red blood cells of rats: in vivo effects. Eur J Haematol 1993;51:86-92.
55. Kumar SV, Bhattacharya S: In vitro toxicity of mercury, cadmium, and arsenic to platelet aggregation: influence of adenylate cyclase and phosphodiesterase activity. In Vitr Mol Toxicol 2000;13:137-144.
56. Kumar SV, Bose R, Bhattacharya S: Low doses of heavy metals disrupt normal structure and function of rat platelets. J Environ Pathol Toxicol Oncol 2001;20:65-75.
57. Folsom AR, Aleksic N, Wang L, Cushman M, Wu KK, White RH: Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study. Arterioscler Thromb Vasc Biol 2002;22:1018-1022.
58. Ishiguro K, Kojima T, Kadomatsu K, Nakayama Y, Takagi A, Suzuki M, Takeda N, Ito M, Yamamoto K, Matsushita T, Kusugami K, Muramatsu T, Saito H: Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest 2000;106:873-878.
59. Bai C, Pan J, Fan L: A study on the deficiency of anticoagulant proteins in Chinese patients with deep venous thrombosis. Zhonghua Nei Ke Za 2000;39:746-748.
60. Macik BG, Ortel TL: Clinical and laboratory evaluation of the hypercoagulable states. Clin Chest Med 1995;16:375-387.
61. Deveci D, Stone PCW, Egginton S: Differential effect of cold acclimation on blood composition in rats and hamsters. J Comp Physiol B 2001;171:135-143.
62. Carr, ME Jr, Carr SL, Martin EJ, Johnson BA: Rapid clot formation and abnormal fibrin structure in a symptomatic patient taking fenfluramine - a case report. Angiology, 2002;53:243.
63. Rodgers GM: Diagnostic approach to the bleeding disorders; in Greer JP, Rodgers GM, Foerster J, Paraskevas F, Lukens JN, Glader B (eds): Wintrobe's Clinical Hematology, ed 11. Philadelphia, Lippincott Williams & Wilkins, 2003, vol 2, chap 51, pp 1517-1520.
64. Brummel-Ziedins K, Orfeo T, Jenny NS, Everse SJ, Mann KG: Blood coagulation and fibrinolysis; in Greer JP, Rodgers GM, Foerster J, Paraskevas F, Lukens JN, Glader B (eds): Wintrobe's Clinical Hematology, ed 11. Philadelphia, Lippincott Williams & Wilkins, 2003, vol 1, chap 21, pp 708-716.